Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bayer Aktienges ADR (OP: BAYRY )

15.22 -0.17 (-1.10%)
Streaming Delayed Price Updated: 1:37 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 882,338
Open 15.33
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 15.39
Today's Range 15.22 - 15.34
52wk Range 11.41 - 18.45
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Evogene Offers An Excellent Risk/Reward Ratio
We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their... 
Via Talk Markets
Bayer Seeks To Double US Revenues Over Next Decade, With Planned R&D Spending Of Around $1B
Bayer AG (OTC: BAYRY) intends to shell out around $1 billion on drug research and development in the U.S. in 2023 as it works to double its sales in the U.S. over the next ten years. 
Via Benzinga

Performance

YTD
+16.90%
+16.90%
1 Month
-2.87%
-2.87%
3 Month
+17.26%
+17.26%
6 Month
+19.28%
+19.28%
1 Year
-7.05%
-7.05%

More News

Read More
EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue
Via Benzinga
Bayer Snags Ex-Roche Exec Bill Anderson As New CEO; Shares Rocket
Via Investor's Business Daily
Investors Always Miss This Key Element
Via Talk Markets
Bayer: Aspirin To Crop Protection
Via Talk Markets
Bayer's Kidney Disease Drug Disappoints On Cutting Cardiovascular Death
Via Benzinga
Ring The Register; Plus, Where To Park Your Profits
Via Talk Markets
Bayer Bolsters Its Position In Digital Medical Imaging With Acquisition Of UK-Based Firm
Via Benzinga
FAA Technology Glitch Hits US Flights Operations, Coca-Cola & PepsiCo Under FTC Probe, Rivian Hit By Mass Executive Exodus: Today's Top Stories
Via Benzinga
Activist Investor Builds Stake In Bayer, Pushes Breakup
Via Benzinga
Key Marijuana Executive Changes: Who Will Lead MariMed After CEO's Passing? MJBiz CEO Steps Down
Via Benzinga
Current Report: Bayer AG
Via Talk Markets
Ionis Regains Rights To Thrombosis Candidate From Bayer
Via Benzinga
Can Acquisitions and Partnerships Take Ginkgo Bioworks (DNA) Stock Higher?
Via InvestorPlace
What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today?
Via InvestorPlace
Elon Musk Renews Twitter's Buyout Proposal, Apple Suppliers Working On Cutting China Reliance, E-Cigarette Maker Considers Bankruptcy: Top Stories Wednesday, Oct. 5
Via Benzinga
Roundup Weedkiller Maker Bayer Won Five Consecutive Cases, Shifting Momentum In Bayer's Favor
Via Benzinga
Top Financial Stories Wednesday, September 14: Multiple Antitrust Setbacks For Google, Bitcoin Crashes, Visa Finds New Gun Control System Ineffective And More...
Via Benzinga
After Investor Flak, German Healthcare Giant Bayer Starts Hunt For New CEO: Report
Via Benzinga
BeiGene's Tislelizumab Shows Non-Inferiority In Overall Survival, Safety Vs Standard Treatment In Solid Tumors
Via Benzinga
Deere Invests Billions In Self-Driving Tractors, Smart Crop Sprayers: Report
Via Benzinga
Regeneron Gains As New Data Favors Higher Dose Of Flagship Eye Disease Drug
Via Benzinga
7 Stocks Under $15 to Buy and Hold Forever
Via InvestorPlace
Bristol Myers Squibb, Bayer Stocks Hit The Deck On Blood Thinner Flops
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.